Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease-Reference-Cited by-同舟云学术

Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease

Published:2014-07 Issue:1 Volume:143 Page:87-110
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Yeganeh Behzad,Wiechec Emilia,Ande Sudharsana R.,Sharma Pawan,Moghadam Adel Rezaei,Post Martin,Freed Darren H.,Hashemi Mohammad,Shojaei Shahla,Zeki Amir A.,Ghavami Saeid

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference416 articles.

1. RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion;Abecassis;Exp Cell Res,2003

2. The functional role of rho and rho-associated coiled-coil forming protein kinase in eotaxin signaling of eosinophils;Adachi;J Immunol,2001

3. Type VIII collagen signals via beta1 integrin and RhoA to regulate MMP-2 expression and smooth muscle cell migration;Adiguzel;Matrix Biol,2013

4. p21(WAF1/CIP1) is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor beta- and Sp1-responsive element: involvement of the small GTPase rhoA;Adnane;Mol Cell Biol,1998

5. Suppression of rho B expression in invasive carcinoma from head and neck cancer patients;Adnane;Clin Cancer Res,2002

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico approach for identification of potential tetracyclic triterpenoids from mushroom as HMG-CoA reductase inhibitor;Aspects of Molecular Medicine;2024-12

2. Statins attenuate Wnt/β-catenin signaling by targeting SATB family proteins in colorectal cancer;2024-08-26

3. Effects of HMGCR deficiency on skeletal muscle development;2024-05-08

4. Statins as anti‐tumor agents: A paradigm for repurposed drugs;Cancer Reports;2024-05

5. Antihyperlipidemic drug rosuvastatin suppressed tumor progression and potentiated chemosensitivity by downregulating CCNA2 in lung adenocarcinoma;Journal of Chemotherapy;2024-01-30